Acute Unilateral Vestibulopathy and Corticosteroid Treatment
Status:
Terminated
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
Randomized placebo controlled trial on patients suffering from acute unilateral
vestibulopathy. Patients will be randomized into 3 arms; 1) Placebo only, 2) Short
corticosteroid treatment (3days) 3) Longer corticosteroid treatment (11 days).
Vestibular function as well as subjective symptoms will be estimated in the acute stage and
regularly up to one year after the debut.